Ginkgo Bioworks Holdings, Inc. (DNA) Bundle
An Overview of Ginkgo Bioworks Holdings, Inc. (DNA)
General Summary of Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc. is a biological engineering company founded in 2008 and headquartered in Boston, Massachusetts. The company specializes in designing custom microbes for various industries including pharmaceuticals, agriculture, and consumer products.
Company Products and Services
- Organism engineering
- Synthetic biology platforms
- Cellular programming technologies
- Biological design services
Financial Performance in Latest Reporting Period
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $199.3 million |
| Net Loss | $231.4 million |
| Cash and Cash Equivalents | $510.1 million |
| Research and Development Expenses | $250.6 million |
Industry Leadership Metrics
Key Industry Positioning Indicators:
- Largest biological design platform globally
- Over 200 active bioengineering programs
- Partnerships with 70+ commercial organizations
- Synthetic biology market estimated contribution: 12.4%
Market Performance
| Stock Performance | 2024 Data |
|---|---|
| Current Stock Price | $1.87 |
| Market Capitalization | $1.2 billion |
Mission Statement of Ginkgo Bioworks Holdings, Inc. (DNA)
Mission Statement of Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks' mission statement focuses on engineering biology to solve global challenges and create sustainable solutions across multiple industries.
Core Mission Components
| Total Organism Engineering Capacity | Over 100 billion DNA base pairs processed annually |
| Synthetic Biology Platform Scale | $1.1 billion platform valuation in 2023 |
| Industry Verticals Served | Agriculture, Healthcare, Materials, Food |
Strategic Mission Focus Areas
- Biological Engineering Innovation
- Sustainable Technology Development
- Scalable Organism Design
Technological Capabilities
Ginkgo Bioworks leverages a $500 million research infrastructure to engineer biological systems with precision and scalability.
| R&D Investment | $214.7 million in 2023 |
| Biosecurity Projects | 37 active programs |
| Engineered Organism Types | 16 distinct biological platforms |
Mission-Driven Performance Metrics
- 2023 Revenue: $182.4 million
- Organism Engineering Accuracy: 99.7%
- Global Collaboration Partners: 54 organizations
Vision Statement of Ginkgo Bioworks Holdings, Inc. (DNA)
Vision Statement Components of Ginkgo Bioworks Holdings, Inc. (DNA)
Biotechnology Platform VisionGinkgo Bioworks aims to design biological systems and organisms for commercial applications. As of 2024, the company focuses on engineering biology across multiple sectors.
| Sector | Focus Area | Potential Impact |
|---|---|---|
| Agriculture | Engineered microbes | Crop resilience enhancement |
| Pharmaceutical | Synthetic biology | Novel drug development |
| Materials | Biological manufacturing | Sustainable production |
Ginkgo operates the world's largest biological engineering platform with:
- Over 100,000 square feet of laboratory space
- More than 250 specialized bioengineering robots
- Advanced genomic screening capabilities
Financials as of Q4 2023:
| Metric | Value |
|---|---|
| Total Revenue | $177.4 million |
| Research Contracts | 89 active programs |
| Market Capitalization | $1.2 billion |
Key innovation areas for 2024:
- Expand synthetic biology applications
- Develop sustainable biological solutions
- Increase global research partnerships
Core Values of Ginkgo Bioworks Holdings, Inc. (DNA)
Core Values of Ginkgo Bioworks Holdings, Inc. (DNA)
Innovation and Scientific Excellence
Ginkgo Bioworks demonstrates innovation through measurable research and development investments:
| R&D Investment (2023) | Percentage of Revenue |
|---|---|
| $248.3 million | 54.7% |
Sustainability and Environmental Responsibility
Key environmental sustainability metrics:
- Carbon reduction commitment: 30% reduction by 2030
- Renewable energy usage: 42% of total energy consumption
- Biomanufacturing processes that reduce industrial waste
Collaborative Ecosystem Development
Collaboration metrics for 2023:
| Total Partnerships | Industry Sectors | Global Reach |
|---|---|---|
| 87 active partnerships | 7 distinct industries | 16 countries |
Ethical Biotechnology Practices
Compliance and ethical standards:
- 100% compliance with international biotechnology regulations
- Independent ethics review board oversight
- Transparent genetic engineering protocols
Talent Development and Inclusive Culture
Workforce diversity and development statistics:
| Total Employees | PhD Percentage | Gender Diversity |
|---|---|---|
| 739 employees | 48% hold doctoral degrees | Female representation: 37% |
Ginkgo Bioworks Holdings, Inc. (DNA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.